Post by Admin on Mar 25, 2024 21:53:33 GMT
Undisclosed Financial Conflicts of Interest in the DSM-5: An Interview with Lisa Cosgrove and Brian Piper
"It's part of the human condition to have biases and to remain blissfully unaware of them. We often assume, quite wrongly, that the scientific process can protect us from those implicit biases."
By James Moore -March 20, 2024
www.madinamerica.com/2024/03/undisclosed-financial-conflicts-of-interest-dsm-lisa-cosgrove-brian-piper/
On the podcast this week we turn our attention to conflicts of interest (COIs) and new research from the British Medical Journal (BMJ). Mad in America has previously examined the problems with conflicts of interest in research but this time we extend that to look at the potential effect of COIs on diagnostic tools such as the Diagnostic and Statistical Manual of Mental Disorders (DSM).
Joining me today are Lisa Cosgrove and Brian Piper, two of the authors of a paper which appeared in the BMJ. The paper is entitled “Undisclosed Financial Conflicts of Interest in the DSM-5 TR: Cross-Sectional Analysis,” and it was published in January 2024.
Lisa Cosgrove is a clinical psychologist and Professor at the University of Massachusetts, Boston where she teaches courses on psychiatric diagnosis and psychopharmacology. A former Research Fellow at the Edmond J. Safra Center for Ethics, Harvard University, her research addresses the ethical and medical-legal issues that arise in organized psychiatry because of academic-industry relationships. She is co-author, with Robert Whitaker, of Psychiatry under the Influence: Institutional Corruption, Social Injury, and Prescriptions for Reform.
Brian Piper is an Associate Professor of Neuroscience at Geisinger Commonwealth School of Medicine in Scranton, PA, with a secondary appointment at the Center for Pharmacy Innovation & Outcomes with Geisinger in Danville, PA. He maintains an active program of research in the pharmacoepidemiology of controlled substances including opioids, cannabinoids, and other controlled substances, behavioral neurology methods development and quantitative medical ethics.
"It's part of the human condition to have biases and to remain blissfully unaware of them. We often assume, quite wrongly, that the scientific process can protect us from those implicit biases."
By James Moore -March 20, 2024
www.madinamerica.com/2024/03/undisclosed-financial-conflicts-of-interest-dsm-lisa-cosgrove-brian-piper/
On the podcast this week we turn our attention to conflicts of interest (COIs) and new research from the British Medical Journal (BMJ). Mad in America has previously examined the problems with conflicts of interest in research but this time we extend that to look at the potential effect of COIs on diagnostic tools such as the Diagnostic and Statistical Manual of Mental Disorders (DSM).
Joining me today are Lisa Cosgrove and Brian Piper, two of the authors of a paper which appeared in the BMJ. The paper is entitled “Undisclosed Financial Conflicts of Interest in the DSM-5 TR: Cross-Sectional Analysis,” and it was published in January 2024.
Lisa Cosgrove is a clinical psychologist and Professor at the University of Massachusetts, Boston where she teaches courses on psychiatric diagnosis and psychopharmacology. A former Research Fellow at the Edmond J. Safra Center for Ethics, Harvard University, her research addresses the ethical and medical-legal issues that arise in organized psychiatry because of academic-industry relationships. She is co-author, with Robert Whitaker, of Psychiatry under the Influence: Institutional Corruption, Social Injury, and Prescriptions for Reform.
Brian Piper is an Associate Professor of Neuroscience at Geisinger Commonwealth School of Medicine in Scranton, PA, with a secondary appointment at the Center for Pharmacy Innovation & Outcomes with Geisinger in Danville, PA. He maintains an active program of research in the pharmacoepidemiology of controlled substances including opioids, cannabinoids, and other controlled substances, behavioral neurology methods development and quantitative medical ethics.